Skip to main content

Press Releases

June 27, 2022
CAMBRIDGE, Mass. , June 27, 2022 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that new research highlighting the company’s internal efforts to develop improved transplant conditioning
Displaying 11 - 20 of 22